Search Results

You are looking at 141 - 150 of 151 items for :

  • "renal cell carcinoma" x
Clear All
Full access

intravenously for 5 days. Results: 18 patients (age 35–52 years; median 54.5 years) were enrolled with brain metastases from solid tumors (5 melanomas, 9 non–small cell lung carcinomas, 2 breast carcinomas, 1 renal cell carcinoma, 1 thyroid carcinoma

Full access

John A. Thompson, Bryan J. Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew Frigault, Brianna Hoffner, Christopher J. Hoimes, Mario Lacouture, Frederick Locke, Matthew Lunning, Nisha A. Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan Oluwole, Sandip P. Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen Wahidi, Yinghong Wang, Alyse Johnson-Chilla and Jillian L. Scavone

a lower incidence of pneumonitis compared with patients with non–small cell lung cancer (NSCLC). Patients with melanoma experienced arthritis and myalgia more commonly than those with renal cell carcinoma (RCC), but patients with RCC experienced

Full access

HR+/HER2− mBC. AB2016-49. Real-World Treatment Patterns and Characteristics Associated With Systemic Therapy in Patients With Advanced Renal Cell Carcinoma: Results from a US Cohort Chart Review Robert Hawkins, MD a ; Caitlyn Solem, PhD b ; Justin

Full access

George D. Demetri, Margaret von Mehren, Cristina R. Antonescu, Ronald P. DeMatteo, Kristen N. Ganjoo, Robert G. Maki, Peter W.T. Pisters, Chandrajit P. Raut, Richard F. Riedel, Scott Schuetze, Hema M. Sundar, Jonathan C. Trent and Jeffrey D. Wayne

renal cell carcinoma (RCC) than in those with non-RCC (19.6%). 115 The relative risks for developing hypertension were 8.2% and 1.42% in patients with RCC and GIST, respectively. Patients should monitor their blood pressure closely, and those who

Full access

Douglas E. Wood, George A. Eapen, David S. Ettinger, Lifang Hou, David Jackman, Ella Kazerooni, Donald Klippenstein, Rudy P. Lackner, Lorriana Leard, Ann N. C. Leung, Pierre P. Massion, Bryan F. Meyers, Reginald F. Munden, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Michael Unger and Stephen C. Yang

.g., malignant pleural mesothelioma, thymic carcinoma). Lung cancer screening may also detect other noncancerous conditions of the thorax (e.g., aortic aneurysm, coronary artery calcification) and tumors or benign disease outside of the chest (e.g., renal cell

Full access

Al B. Benson III, Alan P. Venook, Lynette Cederquist, Emily Chan, Yi-Jen Chen, Harry S. Cooper, Dustin Deming, Paul F. Engstrom, Peter C. Enzinger, Alessandro Fichera, Jean L. Grem, Axel Grothey, Howard S. Hochster, Sarah Hoffe, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Mary F. Mulcahy, James D. Murphy, Steven Nurkin, Leonard Saltz, Sunil Sharma, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Christina S. Wu, Kristina M. Gregory and Deborah Freedman-Cass

trials. 218 In a meta-analysis of 4 studies that included 1,078 patients treated with regorafenib for CRC, gastrointestinal stromal tumor, renal cell carcinoma, or hepatocellular carcinoma, the overall incidence of all-grade and high-grade hand-foot skin

Full access

Steven S. Brem, Philip J. Bierman, Henry Brem, Nicholas Butowski, Marc C. Chamberlain, Ennio A. Chiocca, Lisa M. DeAngelis, Robert A. Fenstermaker, Allan Friedman, Mark R. Gilbert, Deneen Hesser, Larry Junck, Gerald P. Linette, Jay S. Loeffler, Moshe H. Maor, Madison Michael, Paul L. Moots, Tara Morrison, Maciej Mrugala, Louis Burt Nabors, Herbert B. Newton, Jana Portnow, Jeffrey J. Raizer, Lawrence Recht, Dennis C. Shrieve, Allen K. Sills Jr, Frank D. Vrionis and Patrick Y. Wen

mechanical structure. One exception is slow-growing cancers (mainly renal cell carcinoma) with solitary spinal metastasis, for which surgery may achieve cure. 163 The type and aggressiveness of the primary tumor often dictates the choice of treatment

Full access

Peter G. Shields, Roy S. Herbst, Douglas Arenberg, Neal L. Benowitz, Laura Bierut, Julie Bylund Luckart, Paul Cinciripini, Bradley Collins, Sean David, James Davis, Brian Hitsman, Andrew Hyland, Margaret Lang, Scott Leischow, Elyse R. Park, W. Thomas Purcell, Jill Selzle, Andrea Silber, Sharon Spencer, Tawee Tanvetyanon, Brian Tiep, Hilary A. Tindle, Reginald Tucker-Seeley, James Urbanic, Monica Webb Hooper, Benny Weksler, C. Will Whitlock, Douglas E. Wood, Jennifer Burns and Jillian Scavone

kidney cancer . J Urol 2014 ; 191 : 597 – 602 . 56. Keizman D Gottfried M Ish-Shalom M . Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma

Full access

Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher Barker, William E. Carson III, Carlo Contreras, Gregory A. Daniels, Dominick DiMaio, Ryan C. Fields, Martin D. Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas Johnson, Richard W. Joseph, Julie R. Lange, Sameer Nath, Anthony J. Olszanski, Patrick Ott, Aparna Priyanath Gupta, Merrick I. Ross, April K. Salama, Joseph Skitzki, Jeffrey Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian and Anita M. Engh

with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma . Cancer Immunol Immunother 2016 ; 65 : 1533 – 1544 . 27714434 10.1007/s00262-016-1910-x 160. Chesney J , Puzanov

Full access

HBCT patients (median age, 69 years; 27/52 [51.9%] male). Median tumor size was 2.7 cm, 2.2 cm, and 2.1 cm for the ORMB, HBUS, and HBCT patients, respectively ( P =.001). Renal cell carcinoma (RCC) was found in 51/70 (72.9%), 64/103 (62.1%), and 30